Claudius U Meyer
Overview
Explore the profile of Claudius U Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klopp J, Ferretti P, Meyer C, Hilbert K, Haiss A, Marissen J, et al.
mSphere
. 2022 Jan;
7(1):e0080821.
PMID: 35019670
Meconium constitutes infants' first bowel movements postnatally. The consistency and microbial load of meconium are different from infant and adult stool. While recent evidence suggests that meconium is sterile ,...
2.
Meyer C, Zepp F
Methods Mol Biol
. 2021 Dec;
2410:27-56.
PMID: 34914041
Vaccinology has come a long way from early, empirically developed vaccines to modern vaccines rationally designed and produced. Vaccines are meant to cooperate with the human immune system, the later...
3.
Busch M, Grondahl B, Knoll R, Pretsch L, Doganci A, Hoffmann I, et al.
Pediatr Res
. 2019 Jul;
87(5):839-846.
PMID: 31261370
Background: Aberrant immune responses play a key role in the pathogenesis of inflammatory bowel disease (IBD). Most studies conducted to delineate the underlying molecular mechanisms focus on adults; an understanding...
4.
Knoll R, Forslund K, Kultima J, Meyer C, Kullmer U, Sunagawa S, et al.
Am J Physiol Gastrointest Liver Physiol
. 2017 Jan;
312(4):G327-G339.
PMID: 28039159
Current treatment for pediatric inflammatory bowel disease (IBD) patients is often ineffective, with serious side effects. Manipulating the gut microbiota via fecal microbiota transplantation (FMT) is an emerging treatment approach...
5.
Meyer C, Kurlemann G, Sauter M, Wiemer-Kruel A, Hahn A, Doganci A, et al.
Neuropediatrics
. 2015 Sep;
46(5):335-43.
PMID: 26356487
Objective: Therapeutic options for the tuberous sclerosis complex (TSC) syndrome showed varying outcomes. Malfunctional tsc1/tsc2 genes leave mTOR uninhibited, a positive downstream modulator of the innate proinflammatory immune system, which...
6.
Meyer C, Birkholz J, Weins N, Doganci A, Gehring S, Zepp F, et al.
BMC Res Notes
. 2015 Jun;
8:232.
PMID: 26054397
Background: Interleukin-27 (IL-27) has been described to be highly expressed during the very first days after birth, but secretion of IL-27 by dendritic cells during the course of childhood has...
7.
Fichter M, Dedters M, Pietrzak-Nguyen A, Pretsch L, Meyer C, Strand S, et al.
Vaccine
. 2015 Jan;
33(7):838-46.
PMID: 25573037
Enhancing delivery of antigens to dendritic cells (DCs) is essential for the induction of vigorous antigen-specific cellular immune responses. Aim of the present study was to evaluate the properties of...
8.
Diez-Domingo J, Weinke T, de Lomas J, Meyer C, Bertrand I, Eymin C, et al.
Vaccine
. 2015 Jan;
33(6):789-95.
PMID: 25555381
Zostavax(®) is a live, attenuated varicella zoster virus (VZV) vaccine developed specifically for the prevention of HZ and PHN in individuals aged ≥50 years. During the clinical development of Zostavax,...
9.
Osman A, Hitzler W, Meyer C, Landry P, Corduan A, Laffont B, et al.
Platelets
. 2014 Apr;
26(2):154-63.
PMID: 24749844
Pathogen reduction (PR) systems for platelets, based on chemically induced cross-linking and inactivation of nucleic acids, potentially prevent transfusion transmission of infectious agents, but can increase clinically significant bleeding in...
10.
Birkholz J, Doganci A, Darstein C, Gehring S, Zepp F, Meyer C
Hum Immunol
. 2014 Feb;
75(6):584-91.
PMID: 24530744
Interleukin (IL)-27 is known to be increased considerably in cord blood (CB) dendritic cells (DCs) after TLR ligation. Previously, we demonstrated that also basal IL-27 levels are higher in CB...